Why do we need MenB prevention in Australia?

Posted Wednesday 03 July 2024 | GSK

GSK's portfolio of vaccines have been helping to protect people from a range of serious diseases for well over 100 years. 

We are pleased to invite you to an educational meteing which aims to enhance your knowledge of Meningococcal B disease. 

Speaker - Professor Paul Van Buynder 

Please register your attendance to camilla.q.delpy@gsk.com by Thursday 18 August 2022, to reserve your place at this meeting.